BiotechTube
Home/Actinium Pharmaceuticals/Ryan Chu
RC

Ryan Chu

Vice President, Finance and Investor Relations

Actinium Pharmaceuticals

Therapeutic Areas

OncologyHematologic Oncology

Actinium Pharmaceuticals Pipeline

DrugIndicationPhase
Iomab-B (apamistamab-I-131)Relapsed/Refractory AML prior to Bone Marrow TransplantPhase 3
Actimab-A (lintuzumab-Ac-225)Relapsed/Refractory AMLPhase 2/3
ATNM-400Metastatic Castration-Resistant Prostate Cancer (mCRPC)Preclinical
Iomab-ACTConditioning for Cell & Gene TherapiesResearch

Leadership Team at Actinium Pharmaceuticals

SS
Sandesh Seth
Chief Executive Officer and Chairman of the Board
AK
Adeela Kamal
Executive Vice President, Head of Research and Development
JG
Julie Gibson
Vice President, Portfolio and Clinical Operations
PD
Paul Diamond
Vice President, Legal and Intellectual Property Counsel
CD
C. David Nicholson
Lead Independent Director
AS
Ajit Shetty
Director
View full Actinium Pharmaceuticals profile